Pain Management for Cancer Surgery
(LapTAP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests three methods to manage pain during minimally invasive cancer surgeries. The treatments compared include LapTAP (Laparoscopic Transversus Abdominis Plane Block, a pain relief technique using targeted anesthetic blocks) with or without a local anesthetic, and a local anesthetic alone. Researchers aim to determine which option best controls pain, requires the least medication, and causes the fewest side effects. Individuals scheduled for elective cancer surgeries, such as those involving the liver or stomach, who can communicate their pain levels, may be suitable for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative pain management strategies for future patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on long-term opioid or pain medication, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
A previous study found the Laparoscopic Transversus Abdominis Plane Block (LapTAP) to be safe and effective, particularly for abdominal surgeries. This technique manages pain by numbing nerves in the belly area. Research shows that patients tolerate it well with few side effects.
Research indicates that local anesthetics, used to numb specific areas, are generally safe. They are commonly used in surgeries and have a strong safety record, with patients usually experiencing only minor side effects, if any.
Both treatments used in the trial have undergone prior study and are considered safe for managing pain during surgery. Participants might expect typical, mild reactions, but serious issues are rare.12345Why are researchers excited about this trial?
Researchers are excited about the pain management techniques for cancer surgery because they explore different ways to deliver anesthesia effectively. The Laparoscopic Transversus Abdominis Plane (TAP) Block stands out because it involves numbing a specific area of nerves using a minimally invasive approach, which may lead to better pain control and quicker recovery compared to traditional methods like general anesthesia. When combined with local anesthetics, it could provide enhanced pain relief with potentially fewer side effects. These techniques offer the possibility of improving patient comfort and reducing reliance on opioids, which is a major concern in post-surgical pain management.
What evidence suggests that this trial's pain management treatments could be effective for cancer surgery?
Research shows that the Laparoscopic Transversus Abdominis Plane Block (LapTAP), one of the treatments in this trial, effectively reduces pain after minimally invasive surgeries. Studies indicate that it leads to lower pain levels, and patients often require fewer pain medications. This suggests that LapTAP may aid in a more comfortable and quicker recovery after surgery. Local anesthetics, another treatment option in this trial, provide strong pain relief during and after cancer surgeries and reduce the risk of long-term pain issues. Overall, both treatments have proven effective in managing pain in surgical patients.36789
Who Is on the Research Team?
Casey Allen, MD
Principal Investigator
Allegheny Health Network
Are You a Good Fit for This Trial?
This trial is for patients with various abdominal cancers (like liver, stomach, pancreatic) who are undergoing minimally invasive surgery. Participants must be eligible for the surgical procedures and willing to have their pain management method chosen randomly.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo minimally invasive oncologic surgery with one of three pain management regimens: LapTAP with LA, LapTAP only, or LA only
Post-operative Monitoring
Participants are monitored for pain scores, opioid consumption, and adverse events for 24 hours post-surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment until discharge
What Are the Treatments Tested in This Trial?
Interventions
- Laparoscopic Transversus Abdominis Plane Block
- Local Anesthesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Lead Sponsor